Dose Escalation Study Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dose Escalation Study Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dose Escalation Study Data Today - Breaking & Trending Today

Foghorn Therapeutics Announces FDA Has Lifted Clinical Hold on Phase 1 Study of FHD-286 in Relapsed and/or Refractory AML/MDS Patients

Published: June 5, 2023

- Plan to Initiate a Phase 1 Study of FHD-286 in Combination with Decitabine or Cytarabine in Relapsed and/or Refractory AML Patients in Q3’2023 - Clinical and Pre-Clinical... | June 5, 2023

Source: marketscreener.com

Related Topics:

United KingdomUnited StatesKarin HellsvikMartin TallmanEytan SteinHans VitzthumMichael LampeAdrian GottschalkTherapeutics IncCompany Annual Report On FormExchange CommissionDrug AdministrationFoghorn Therapeutics IncProgram For Drug Development In LeukemiaLeukemia ServicePre Clinical Data SuggestReiterates GuidanceCash RunwayChief Executive OfficerClinical InvestigatorDrug DevelopmentMemorial Sloan Kettering CancerDose Escalation Study DataNorthwestern MemorialGene Traffic